Are Cannabis Revenues Leveling Off?

Cannabis stocks, including Neptune Wellness (TSX:NEPT) and Canopy Growth (TSX:WEED)(NYSE:CGC), reported declines in revenue, which sent the stock prices lower.

| More on:

Cannabis stocks are popular among many TSX investors in Canada, and for a good reason. High revenue growth is a crucial driver for strong price performance on the stock exchange. Because the marijuana industry is new, cannabis companies should experience increasing revenue growth post-legalization.

This week’s earnings didn’t turn out quite as well as shareholders would have hoped. Instead of continued surges in revenue, cannabis stocks, including Neptune Wellness (TSX:NEPT) and Canopy Growth (TSX:WEED)(NYSE:CGC), reported declines in revenue, which sent the stock prices lower. What happened?

Canopy Growth accredited lower-than-projected new store growth and already high province inventory levels for the lower revenue. Meanwhile, Neptune Wellness — a cannabis company more focused on health products — cited order timing as the primary driver for the lower income.

Canopy Growth

Canopy Growth’s net revenue came in lower than expected at $76.6 million — a 15% decrease from the previous quarter’s revenue of $90.5 million.

“The last two quarters have been challenging for the Canadian cannabis sector as provinces have reduced purchases to lower inventory levels, retail store openings have fallen short of expectations, and Cannabis 2.0 products are yet to come to market,” said Mark Zekulin, the CEO of Canopy Growth.

Provinces purchase marijuana from Canopy Growth, but they began accruing high inventory levels. In response, the regions purchased less new inventory. Once many of the new stores open, the provinces will build up stocks once again, and revenue will rise.

However, international medical cannabis revenues soared last quarter by 72% to $18.1 million from 10.5 million. The company is expanding quickly overseas, and that should offset seasonal fluctuations in the North American market.

Neptune Wellness

Neptune Wellness reported a year-over-year decrease in revenue on Monday for the quarter ended September 30, 2019. Net revenue was 8% lower at $6.52 million compared to $7.1 million for the same quarter last year, right after the first wave of marijuana legalization.

The company credits the timing in the orders for the decrease in revenue. Order timing can affect orders between quarters, which is why six-month and yearly averages can be more helpful when assessing changes in demand for a specific brand.

Neptune Wellness is different from other marijuana corporations in that it sells hemp-derived nutrition products. The marijuana industry has taken a few hits recently, beginning with lung injuries from THC vaping products. Neptune has been largely shielded from this tragedy because it markets ingestible chewables, soft gels, roll-ons, sprays, and oils.

Foolish takeaway

It may be counter-intuitive to think that marijuana is a seasonal industry, but it is an agricultural product. Planting cycles create harvest seasons where supply will start booming — and that is when the retailers will make significant purchases.

Canadian investors will want to take note of the rise and fall in inventory orders to make counter-cyclical purchases in stock. When the stock price falls along with revenue, it would be a good idea to pick up new positions.

Timing the market is difficult and not recommended, but on seasonal stocks, find dependable companies that you don’t mind owning for the next 30 years and buy when the shares are low to make the most out of your retirement savings.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Debra Ray has no position in any of the stocks mentioned.

More on Stocks for Beginners

up arrow on wooden blocks
Tech Stocks

The 3 Smartest Tech Stocks to Buy With $500 Right Now

Tech stocks can be seen as a bit risky, but these three have far less risk and more stability for…

Read more »

shopper buys items in bulk
Dividend Stocks

Where to Invest $7,000 in November

This consumer staples company provides consistent stock performance alongside a dividend.

Read more »

A worker gives a business presentation.
Stocks for Beginners

Is TMX Group Stock a Buy, Sell, or Hold for 2025?

There are a lot of items to consider when looking at TMX Group as an investment. Today, let's get into…

Read more »

man shops in a drugstore
Stocks for Beginners

3 Consumer Stocks That Canadians Need to Watch in November

Consumer staple stocks could turn these stocks even higher with the holidays coming up.

Read more »

a sign flashes global stock data
Stocks for Beginners

Safe Canadian Stocks to Buy Now and Hold During Market Volatility

Adding these two safe Canadian stocks to your portfolio now could make your portfolio more stable despite short-term market volatility.

Read more »

shopper chooses vegetables at grocery store
Dividend Stocks

Is Loblaw Stock a Buy for Its 1.2% Dividend Yield?

Loblaw stock may not have the highest dividend yield out there, but what does that really mean to today's investor?

Read more »

cloud computing
Tech Stocks

Best Stock to Buy Right Now: Manulife vs CIBC

Want the best stocks? These two are certainly the best options. But which is the better buy?

Read more »

construction workers talk on the job site
Energy Stocks

Best Stock to Buy Right Now: Baytex vs Suncor?

Suncor and Baytex stocks both look like solid companies offering growth and dividends. But which is the better buy?

Read more »